Ambea AB (CHIX:AMBEAS) Beta: -0.9298 (As of Jun. 26, 2026)


CHIX:AMBEAS Ambea AB CHIX:AMBEAS
82 GF Score
Price kr140.40
GF Value kr110.05
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ambea AB Beta?

Ambea AB CHIX:AMBEAS 82 Beta is -0.9298 as of Jun. 26, 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 82/100 and a GF Value™ of kr110.05 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Ambea AB's Beta is -0.9298.


Ambea AB  (CHIX:AMBEAs) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Ambea AB Beta Related Terms


Ambea AB Beta Historical Data

* Premium members only.

The historical data trend for Ambea AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB Beta Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.58 0.05 -0.88

Ambea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.02 -0.10 -0.88 -0.74

CHIX:AMBEAS vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Ambea AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambea AB Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's Beta distribution charts can be found below:

* The bar in red indicates where Ambea AB's Beta falls into.


CHIX:AMBEAS
82GF Score
Ambea AB CHIX:AMBEAS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambea AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.9298 mean?
Ambea AB (CHIX:AMBEAS) has a Beta of -0.9298 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ambea AB and its competitors.
Is Ambea AB's Beta too high?
Ambea AB's current Beta is -0.9298. Overall, Ambea AB has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Beta compare to HCA and THC?
Ambea AB's Beta of -0.9298 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ambea AB and its competitors. Ambea AB's current Beta is -0.9298. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr110.05, compared to a current price of kr140.40 — trading 27.6% above its estimated fair value. The current Beta is -0.9298. Ambea AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Beta is -0.9298 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of kr140.40 is trading 27.6% above its estimated GF Value™ of kr110.05. GuruFocus considers Ambea AB to be Modestly Overvalued.

Key valuation signals for CHIX:AMBEAS:

  • Beta: -0.9298
  • GF Value™: kr110.05 vs. price of kr140.40 (27.6% above fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
82GF Score

Get the complete analysis for CHIX:AMBEAS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr140.40
Price
kr110.05
GF Value